Direct Acting Antiviral-Post Authorization Safety Study
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention
- Status
- COMPLETED
- Phase
- NA
Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population
- Status
- COMPLETED
- Phase
- N/A
Dual and Single Switching Monopolar RFA Using Separable Clustered Electrode for Treatment of HCC
- Status
- COMPLETED
- Phase
- NA
A Prospective Cohort Study of Patients with Hepatobiliary Cancer Treated with Immune Checkpoint Inhibitors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
- Status
- RECRUITING
- Phase
- NA
Safety and Bioactivity of Ipilimumab and Nivolumab Combination Prior to Liver Resection in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Multi-center Study on Therapy-oriented Molecular Subtyping of Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
APL-501 or Nivolumab in Combination With APL-101 in Locally Advanced or Metastatic HCC and RCC
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
[68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
DKN-01 Inhibition in Advanced Liver Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment
- Status
- TERMINATED
- Phase
- N/A
Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
CTLA-4 /PD-L1 Blockade Following Transarterial Chemoembolization (DEB-TACE) in Patients With Intermediate Stage of HCC (Hepatocellular Carcinoma) Using Durvalumab and Tremelimumab
- Status
- COMPLETED
- Phase
- PHASE2
TACE Combined With RFA/MV Treatment in Hepatocellular Carcinoma Beyond Milan Criterial
- Status
- COMPLETED
- Phase
- PHASE3
Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation
- Status
- TERMINATED
- Phase
- PHASE2
Computer-assisted Tumor Ablation for Patients With Liver Cancer
- Status
- COMPLETED
- Phase
- N/A
Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- N/A